A Migraine Toolbox: A Practical Approach to Diagnosis and Treatment - Module 2: Treatment

The second learning module simplifies the process of determining migraine treatment programs. By its conclusion, you should be confident that you have the skills to manage patients with migraine. Your strategy should include identification and avoidance of triggers, effective lifestyle changes, and familiarity with the pros and cons of interventional and preventive medications and devices. There will be brief reviews of the different options in neuromodulation, CGRP blockers and medical marijuana.

Target Audience

For any non-headache specialist healthcare professionals who encounter patients with migraine.

Learning Objectives

Upon completion of these activities, participants should be better able to:

  • Describe how to create a treatment plan which includes appropriate medications and alternative therapies
  • Identify migraine triggers
  • Describe effective lifestyle changes for migraine disease
  • Compare and contrast both preventive and interventional medications for migraine disease
  • Describe different options in neuromodulation
  • Describe the pros and cons of CGRP blockers
  • Explain the evidence behind treatment of migraines with medical marijuana
Course summary
Available credit: 
  • 2.00 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Enduring activity for a maximum of 2.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 2.00 ANCC
  • 2.00 Participation
Course opens: 
01/01/2022
Course expires: 
12/31/2022
Rating: 
0

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Boston University School of Medicine and Association of Migraine Disorders. Boston University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

Boston University School of Medicine designates this enduring material for a maximum of 2.00 AMA PRA Category 1 Credits TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Accreditation Statement

This educational activity has been provided by Continuing Nursing Education Provider Unit, Boston University School of Medicine and jointly-provided by Association of Migraine Disorders.

Continuing Nursing Education Provider Unit, Boston University School of Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Designation Statement

Contact Hours: 2.00 of which 2.00 are eligible for pharmacology credit.

Available Credit

  • 2.00 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Enduring activity for a maximum of 2.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 2.00 ANCC
  • 2.00 Participation
Please login or register to take this course.